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SUMMARY
BACKGROUND—The burden of tuberculosis (TB) in the estimated 370 million indigenous 
peoples worldwide is unknown.
OBJECTIVE—To conduct a literature review to summarize the TB burden in indigenous peoples, 
identify gaps in current knowledge, and provide the foundation for a research agenda prioritizing 
indigenous health within TB control.
METHODS—A systematic literature review identified articles published between January 1990 
and November 2011 quantifying TB disease burden in indigenous populations worldwide.
RESULTS—Among the 91 articles from 19 countries included in the review, only 56 were from 
outside Australia, Canada, New Zealand and the United States. The majority of the studies showed 
higher TB rates among indigenous groups than non-indigenous groups. Studies from the Amazon 
generally reported the highest TB prevalence and incidence, but select populations from South-
East Asia and Africa were found to have similarly high rates of TB. In North America, the Inuit 
had the highest reported TB incidence (156/100 000), whereas the Metis of Canada and American 
Indians/Alaska Natives experienced rates of <10/100 000. New Zealand’s Maori and Pacific 
Islanders had higher TB incidence rates than Australian Aborigines, but all were at greater risk of 
developing TB than non-indigenous groups.
CONCLUSION—Where data exist, indigenous peoples were generally found to have higher rates 
of TB disease than non-indigenous peoples; however, this burden varied greatly. The paucity of 
published information on TB burden among indigenous peoples highlights the need to implement 
and improve TB surveillance to better measure and understand global disparities in TB rates.
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Although the estimated 370 million indigenous people worldwide1 comprise <5% of the 
global population, evidence from nations where surveillance data exist suggests that the 
burden of tuberculosis (TB) falls heavily on indigenous peoples2–6 and that they are 
disproportionately affected.7 Furthermore, of the estimated 8.8 million new cases of TB 
occurring each year, the burden and current state of TB in the indigenous peoples inhabiting 
more than 70 countries globally are not known. The Strategic Framework for Action on TB 
Control in Indigenous Communities emphasizes the need to increase the awareness and 
surveillance of TB among indigenous peoples by documenting and highlighting the 
incidence and burden of TB in these groups.8
Given the lack of information about TB among the world’s indigenous peoples, this 
systematic literature review was conducted to better understand, document and summarize 
the burden of TB in indigenous peoples, identify gaps in our knowledge, develop 
recommendations for future work and provide the foundation to set an appropriate research 
agenda prioritizing indigenous health within TB control.
METHODS
Search strategy
A systematic literature review using the PRISMA (Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses) framework9 was conducted of articles related to the 
epidemiology of TB in indigenous populations published during January 1990–November 
2011, focusing on articles that quantified the burden of TB disease in indigenous groups. 
PubMed was used to search biomedical literature from Medline, journals and online books. 
CabDirect was used to ensure that articles published on global issues in the applied life 
sciences were also searched. Subject and keyword terms used in this review are listed in 
Table 1.
The United Nation’s definition of indigenous peoples, i.e., any group of people who self-
identify as indigenous to be indigenous, was used in this paper.1,10 For countries with 
disaggregated TB data, indigenous status is largely self-reported; in these countries, the 
names of the indigenous groups were used for the systematic search. To ensure that the 
search was comprehensive, names of indigenous groups from nations where disaggregated 
data do not exist were gathered from Bartlett et al.’s article on indigenous people and global 
health research,10 and from organizations representing regional indigenous issues to the 
United Nations Permanent Forum on Indigenous Issues (UNPFII), specifically the 
Indigenous Peoples of Africa Coordinating Committee,11 the Russian Association of 
Indigenous Peoples of the Far North12 and the Asia Indigenous Peoples Pact.13 In addition, 
country reports submitted to the UNPFII and relevant conference abstracts on indigenous 
health were used to ensure as broad and inclusive a search strategy as possible.
Study selection
Articles of any language were included if they provided data on the burden of TB disease in 
indigenous populations that were 1) collected during or after 1990 in Australia, Canada, 
New Zealand or the United States, or 2) collected during or after 1985 in any other country. 
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We allowed the five additional years of data where research was infrequent to maximize the 
number of indigenous groups represented in this study. Primary and secondary research 
articles, including published government reports, were included. The references of included 
articles were reviewed to identify additional papers of interest. To ensure the most 
comprehensive review, studies of all sizes and scope were included. Published literature 
reviews summarizing findings for a particular group were not included in this review but 
were read to identify pertinent sources. Articles with unclear methodology regarding 
incidence or prevalence calculations were excluded (Figure 1).
Data extraction
The World Health Organization (WHO) regions were used to organize articles based on the 
geographic location of the studies. The region of the Americas was further divided into 
North and Latin America, the latter including Mexico and the Caribbean. Two authors 
independently reviewed abstracts and articles for each region and came to a consensus on 
the inclusion or exclusion of each article. Authors extracted the data using a standardized 
format developed based on study objectives, a review of similar studies, and the variables 
needed. Authors verified the extracted data and came to a consensus when discrepancies 
arose.
The following variables were collected from each included study: location, including 
country and province or region; name of indigenous groups(s); study design; scope of study; 
year(s) data were collected; number of people studied; reported burden of TB (incidence or 
prevalence per 100 000 population); and the TB burden in a local non-indigenous 
population. TB incidence and/or prevalence were calculated if the number of TB cases and a 
population estimate were provided. If TB rates in a local non-indigenous population were 
not provided, the WHO-reported national TB incidence or estimated prevalence for the year 
data were collected was used for comparison; if the study occurred over multiple years, the 
WHO reported rate was chosen for the final year of data collection. From these data, a ratio 
was calculated to estimate the differences in TB incidence and/or prevalence in indigenous 
and non-indigenous groups.
RESULTS
Subject and keyword searches conducted in PubMed and CabDirect identified 534 unique 
articles. Four additional articles were identified from the references of papers read. Ninety-
one articles related to TB in indigenous peoples in 19 countries were included in the review 
(Figure 2). Over three quarters of the included articles were published during 2000–2011, 
but the most recent available data on TB in indigenous populations varied widely between 
regions and countries. Twenty-seven of 35 articles from countries with disaggregated data 
were published after 2000; 16 of 18 studies from Latin America and 17/21 studies from 
South-East Asia were also published after 2000; and studies from the African, Eastern 
Mediterranean and European regions were largely published before 2000.
There was also substantial variation in the design and scope of the studies included in the 
review, specifically between countries that had disaggregated national TB surveillance data 
and those that did not. Many included articles were based on studies of small populations, 
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reporting no levels of statistical uncertainty; as such, the quality of data within the studies 
varied. Table 2 summarizes the methodology and scope of the included literature.
TB burden by region
African Region—Although the estimated number of indigenous people living in Africa is 
14.2 million,10 only two studies from the African region fulfilled the inclusion criteria for 
this review. The included studies relied on small community health surveys, accompanied by 
medical examinations or reviews of hospital records, to assess TB status within indigenous 
populations.14,15 The available data suggest that the prevalence of TB may be substantially 
higher among indigenous than non-indigenous African populations. The prevalence of TB 
disease was found to exceed 4000/100 000 among the nomadic Fulani in Chad,15 and 1800 
among the Peul and Dogon peoples in Mali (Table 3).14
The Americas: North America—The indigenous groups of North America included in 
the review are comprised broadly of the following: First Nations (or North American 
Indians), Metis and Inuit in Canada, and American Indians (AI), Alaskan Natives (AN), 
Native Hawaiians (NH) and Pacific Islanders (PI) in the United States. Approximately 4.4% 
of Canada’s population reported some indigenous ancestry as of 2009,10 and in the United 
States, 2.3 million and 435 000 persons were identified solely as respectively AI/AN and 
NH/PI in 2008.44 There are many published studies on the TB burden among indigenous 
groups living in the United States and Canada. Studies from these two countries 
predominantly included retrospective reviews based on national governmental surveillance 
data (Table 3).
The most recent data indicate that TB incidence continues to be substantially higher among 
indigenous groups across Canada and the United States than among non-indigenous groups.
6,16,17,44–64
 In the United States, AI/AN and NH/PI had 6.8 and 22.9 times greater TB 
incidence than Whites in 2010.6,16 TB incidence rates in NH/PI are higher than in AI/AN,
6,16,44,59
 but tribal-specific data, such as among the Oglala Sioux, reveals pockets where TB 
incidence is much higher.47 From 2008 to 2010, TB incidence rose for both AI/AN and 
NH/PI, but overall TB incidence has decreased among both groups in the last two decades.53
TB incidence in indigenous populations in Canada is higher than in the United States. The 
northern tribes of Canada are most affected by TB: in 2009, TB incidence was 155.8/100 
000 among Canada’s Inuit, over 150 times the rate among non-aboriginals born in Canada.17 
In comparison, national TB incidence among the Metis and the First Nations peoples were 
respectively 7.3 and 27.4 times higher than in non-aboriginal Canadians.17
The Americas: Latin America and the Caribbean—It is estimated that Latin America 
is home to 450 indigenous groups comprised of 34 million people, which make up 8% of the 
region’s total population.10 In Brazil alone, there are an estimated 220 indigenous groups 
composed of 450 000 people, more than 60% of whom live in the Brazilian Amazon.65 The 
majority of the studies from this region included in this review were from the Brazilian 
Amazon,19,20,22,23,66–74 with fewer studies coming from Ecuador, Paraguay, Peru and 
Venezuela (Table 3; Appendix*).18,21,24–26 No studies from the Caribbean, Mexico or 
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Central America were found that fit the study criteria, although indigenous communities 
make up large parts of their populations.10
Overall, indigenous peoples across Latin America were found to have extremely high 
burdens of TB. Brazilian Amazonian groups were some of the most affected, with TB 
incidence rates often exceeding 1000/100 000, or at least 20 times higher than the incidence 
in the general Brazilian population.67,70,73 In particular, the most recent study of the 
Yanomami people found the incidence of TB to be 2133/100 000, or 37 times higher than in 
the surrounding non-indigenous population;72 the prevalence of TB among the Yanomami 
was estimated to be up to 94 times higher than in the provincial population.73 Indigenous 
people living in Cotopaxi Province in Ecuador’s highlands had TB prevalence rates reaching 
6700/100 000, over 40 times Ecuador’s national prevalence.24 A study of the Ache of 
Paraguay reported a TB incidence 75 times greater than the national incidence.18
Conversely, certain indigenous groups were found to have a TB burden lower than or equal 
to their non-indigenous counterparts. In Peru, for example, one study found a TB incidence 
in indigenous peoples similar to or lower than in the general population.21 Within this study, 
many Amazonian tribes, such as the Aguaruna, Nomastshiguenga, Shawi and Shapra, had 
TB incidence rates of 0.4–0.9 times the national incidence.21 In addition, a study among 
indigenous children (aged <15 years) in southwestern Brazil showed that TB incidence 
decreased between 2001 and 2006, attributed in part to a new TB control strategy that had 
been implemented.23
Eastern Mediterranean Region—This review identified one study quantifying the 
burden of TB among Bedouins in Israel, which found TB incidence to be 18.1/100 000 in 
1987, approximately twice as high as the 1990 national Israeli TB incidence.27
European Region—The indigenous peoples of Europe are generally considered those 
who adhere to traditional lifestyles in the Far North. Over 40 broadly defined indigenous 
populations are recognized in Greenland, Scandinavia and Russia, including the Inuit, the 
Sami, and the Nenets, Chukchi and Evenks, respectively.10,63 The Roma are also considered 
an indigenous group prominent in this region.75
The largest and most recent studies quantifying the TB burden in Europe were conducted in 
Greenland,29,76 where 80% of persons are indigenous Inuit (Table 3).10 From 1990 to 2001, 
the incidence of active TB increased in this population from 85 to 185 cases/100 000.76 
Furthermore, the most recent study found that the odds of developing active TB were 15.3 
times higher in indigenous groups compared to those of Danish heritage.29
Outside Greenland, there was much less information from the European region. Although 
Scandinavia is estimated to have approximately 70 000 Sami,63 no studies were found that 
described the burden of TB within this population, and government data for TB in areas 
where the Sami predominantly reside were not disaggregated.63 Very little is also known 
about TB within the Roma population;75 only one study conducted among Roma was 
*The Appendix is available in the online version of this article at http://www.ingentaconnect.com/content/iuatld/ijtld/
2013/00000017/00000009/art00005
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identified for this review, which found the Roma in Barcelona to have a TB incidence 5.3 
times greater than Spain’s national TB incidence.30
More than 280 000 indigenous persons are estimated to live in Russia,63 but studies 
quantifying TB incidence or prevalence within these populations were sparse and limited in 
scope.28,77–80 The data that exist show indigenous peoples to be substantially more burdened 
by TB than their non-indigenous counterparts. In areas of northeastern Russia, TB 
prevalence was found to be 10 times higher among indigenous than non-indigenous persons.
77
 However, data suggest that the TB burden has been declining, narrowing the gap between 
indigenous and non-indigenous groups in Russia.28,79 No studies with data collected within 
the last decade were found for this review, and thus the current TB burden among the 
indigenous of Russia’s Far North is largely unknown.
South-East Asia Region—It is estimated that three quarters of the world’s indigenous 
people live in Asia, with over 250 indigenous groups residing in India and 60 in Thailand 
alone.10 Despite the large number of indigenous people in Asia, data quantifying the burden 
of TB were only readily available from India.
Within India, the majority of studies were conducted in the central state of Madhya Pradesh, 
where tribal groups account for more than 25% of the total population (Table 3).32–37,81–83 
Data on TB burden were primarily gathered through cross-sectional surveys conducted by 
academic institutions and medical research centers.
In India, the majority of tribal groups demonstrated higher TB burdens than non-tribal 
peoples.32,34–37,81–83 The Saharia were the most disproportionately affected, with a TB 
prevalence from 5 to >100 times greater than India’s national TB prevalence.32,37,83 The 
differential burden was smaller, but still substantial, between other tribal groups and the 
national prevalence estimates. For example, the prevalence of TB among the Bhil, Bharia 
and Nicobarese tribes was 1.3–8.0 times greater than the estimated national TB prevalence, 
while the Baiga and Jawadhu Hills tribes were found to have TB prevalence measurements 
45–50% lower than national estimates.33,84
Although the burden of TB was largely found to be greater in indigenous than the non-
indigenous groups in India,85 TB prevalence varied widely between groups even within the 
same geographic region. Within Madhya Pradesh, TB prevalence was documented to be 
0.15% among the Baiga33 and 0.43% among the Bharia,34 but between 1.4% and 46% 
among the Saharia tribal groups.35–37,83 In a study conducted in Maharashtra State, active 
TB was identified in only six of 46 tribal groups.38 However, in tribes where active TB was 
observed, TB prevalence reached 730/100 000, five times greater than the provincial TB 
prevalence.38
The data also suggest that changes in the TB burden over time have been variable within 
tribal groups. In Tamil Nadu’s Jawadhu Hills Tribes, TB prevalence decreased by four fold 
from 1989 to 1993.82,84 However, only a minimal decline in TB has been observed among 
the Saharia between 1991 and the present,36,37,82 with reports of increased burden in some 
areas.83
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Western Pacific Region—The Western Pacific is home to many indigenous peoples: the 
Aborigines and Torres Strait Islanders descendants in Australia; the Maori and Pacific 
Islanders in New Zealand; the mountainous aborigine of Taiwan; fifty-five ethnic minority 
groups in China; and hills peoples and other aborigine groups in the Philippines, Indonesia, 
Viet Nam and surrounding nations.10 However, data on TB burden were available only for 
Australia, New Zealand, Taiwan and, to a lesser extent, China (Figure 2). The available data 
indicate that TB continues to disproportionately affect the indigenous populations of the 
Western Pacific Region (Table 3).
The incidence of TB was lower among the indigenous populations in Australia and New 
Zealand than in many regions of the world, but in comparison to the non-indigenous 
populations, the indigenous groups were disproportionately burdened with TB. Although TB 
incidence has decreased among Australian Aborigines in the past years,4,86–90 incidence 
rates remain over seven times higher among Aborigines than among Australian-born non-
Aborigines.4 In Southern Australia and the Northern Territory, Aborigines are most 
disproportionately affected by TB,89,90 and have a 13 times higher TB incidence than their 
non-Aborigine counterparts.4
In New Zealand, Pacific Islanders were consistently found to have higher rates of TB than 
the Maori, but both groups have substantially higher TB incidence than their non-indigenous 
counterparts.5,91–93 The most recent studies report TB incidence to be respectively 14.3 and 
34.1 times higher in Maori and Pacific Islander populations than in the non-indigenous New 
Zealandborn.5 Although the most recent data suggest that TB rates have declined among the 
Maori and Pacific Islanders in the past 15 years,5 earlier data reveal lower incidence rates 
among the indigenous population than currently observed.92,93
As was the case for Australia and New Zealand, the burden of TB in the Taiwanese 
indigenous people is well documented. The most recent measure found TB incidence to be 
2.7 times greater for Taiwanese residing in aborigine areas than those in non-aborigine areas.
43
 Comparing this study to earlier studies suggests that TB incidence within the indigenous 
population has been falling in the last 10 years, although there remains a substantial 
difference in TB rates between indigenous and non-indigenous peoples.43,94–97
Data on TB burden for ethnic minorities in China were scarce. Although not considered 
indigenous peoples by the national government, many scholars assert that China’s ethnic 
minorities fit definitions of indigenous.10 Existing data are older, with two of the three 
included studies published more than 20 years ago.98,99 In 1985, a TB incidence of 
6500/100 000 was reported among the E-Lun Chun, a northeastern ethnic group;98 
otherwise no other studies of these people were found. Surveillance data from 1990 show 
TB prevalence to be highly variable among ethnic minorities, ranging from 47/100 000 for 
the Bai people to 274/100 000 for the Uyghur, prevalence rates that were respectively 35% 
of the estimated national prevalence and over twice the estimated national prevalence.99 The 
most recent data suggest that ethnic minorities in Sichuan Province are substantially more 
burdened than any of the nation’s ethnic groups measured in 1990.100
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Indigenous peoples as refugees—Circumstances have led some indigenous peoples to 
leave their homelands and settle in other countries, sometimes as refugees. Among such 
groups, data on TB burden for Tibetan and Hmong refugees were available. The incidence of 
TB for Tibetan refugees living in India was 3.9 times greater than India’s national TB 
incidence, with Tibetans living in central and south India largely more affected than those in 
northern India.42,101 Outside of India, the Tibetan refugee communities screened for TB in 
Minnesota, USA, and Toronto, Canada, had a TB incidence of >4000/100 000.102,103 In 
comparison, reported TB incidence rates were lower among Hmong refugees, but the 
Hmong people still had higher TB rates than non-indigenous peoples. Hmong living as 
refugees in Thailand had a nine times higher TB prevalence than the Thai national rate.41,104 
Another study found the TB incidence among Hmong in Minnesota, USA, to be 1600/100 
000.102
DISCUSSION
This is the first systematic review of the literature to examine the TB burden in indigenous 
populations globally. We found that indigenous peoples in high-, middle- and low-income 
countries continue to bear a high and disproportionate burden of TB, but this burden varies 
greatly between groups and regions. The most recent available data suggest that the groups 
most burdened by TB are located in small regions of Latin America (e.g., the Ache in 
Paraguay and the Yanomami in Brazil), followed closely by tribes in India (e.g., the Saharia, 
in Madhya Pradesh) and Africa (e.g., the Fulani, in Chad). The groups least burdened by TB 
live in high-income countries. Aboriginal Australians, American Indians/Alaskan Natives 
and the Metis of Canada were found to have the lowest incidence of TB disease among 
indigenous groups, but the differential TB burden between indigenous and non-indigenous 
populations in these industrialized nations was greater in many studies than for those in 
developing nations. Within these industrialized countries, Pacific Islanders, First Nations and 
the Canadian Inuit bear an especially disproportionate burden of TB. Select groups in Latin 
America and India also had a highly disproportionate burden of TB, although some tribes 
from these regions had minimal or no differences in disease burden. Moreover, although the 
available data suggest that the TB burden has decreased among some groups, such as the 
Australian Aborigines,4,86–88 Taiwanese Aborigines,43,95 Russia’s Far North peoples,28,79 
and the AI/AN and NH/PI in the United States,6,16,44,53,59 disparities in TB case rates 
remain. These continuing disparities highlight the importance of prioritizing indigenous 
health in TB control efforts. They also highlight the need to have TB control strategies that 
are designed and implemented by and for indigenous communities that incorporate unique 
indigenous perspectives and values, as proposed by the Strategic Framework for Action on 
Tuberculosis Control in Indigenous Communities.8 Such strategies should be tailored to the 
distinctive cultural, social and historic realities of indigenous groups to effectively address 
the TB burden in different regions.
This review also demonstrates the paucity of available data on the TB burden among 
indigenous populations outside Australia, Canada, the United States and New Zealand. 
Although millions of indigenous peoples live in Africa, Asia and Latin America,10 little is 
currently known about how TB affects these populations. Specifically, no studies were found 
for the tribal groups of the Caribbean, Central America or the Middle East, and TB data 
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were lacking for the majority of tribes in the Far North (e.g., the Sami, the Nenets), South-
East Asia/Western Pacific (e.g., indigenous of Malaysia, Cambodia, Viet Nam, Indonesia 
and the Philippines) and Africa. Published data from these regions included in this review 
often originated from small studies, as opposed to publications from Australia, Canada, the 
United States and New Zealand, which generally used national-level surveillance data. This 
suggests that there is not only a shortage of data but also a paucity of high-quality data, 
specifically disaggregated national-level surveillance data, that allows for the estimation of 
TB case rates in different racial/ethnic groups. This reveals the need to increase and improve 
TB surveillance among indigenous populations. Where strong TB surveillance already exists 
(e.g., Scandinavia, India), disaggregated data are needed for routine monitoring of TB rates 
and the effectiveness of TB control in indigenous groups. For example, adding a single 
variable (e.g., race/ethnicity) to the national TB surveillance system could inform the 
development of evidence-based policies and practices to effectively address TB among 
indigenous peoples. In countries or provinces where strong TB surveillance does not yet 
exist, operational research assessing the burden of TB within indigenous groups is needed. 
Furthermore, additional research is needed to assess the extent to which drug-resistant TB, 
TB-HIV (human immunodeficiency virus), other comorbidities (e.g., diabetes) and the 
burden of TB in children affects indigenous communities.
While the primary aim of this study was to document and summarize the burden of TB in 
indigenous peoples, this review highlights the need to elucidate reasons for the 
disproportionately high TB burden among these groups. Social determinants of health are 
important contributors to the burden of TB among indigenous peoples, who account for 
approximately 15% of the world’s poor105 and face disparities in terms of employment, 
income, and access to and quality of education and health care.44,106 Poverty is a key 
obstacle in accessing health care, including prompt TB diagnosis with sensitive tools and 
appropriate treatment.54 Measures that increase indigenous people’s access to quality TB 
diagnosis and treatment are therefore needed to improve case detection and ensure improved 
and targeted health service delivery to marginalized indigenous groups.106 Successful 
models of health care in indigenous peoples exist. For example, despite the structural, 
economic and programmatic barriers to health faced by many AI/AN communities, a study 
from the United States found that AI/ANs more commonly received totally directly observed 
therapy (DOT) and had similar treatment completion rates compared with other racial/ethnic 
groups.44 The availability of DOT through the United States’ Indian Health Service (lHS), 
tribal, and urban Indian health care facilities and other partners, may have contributed to 
declines in case rates. Additional research is needed to examine structural and programmatic 
reasons for why the TB burden is higher in many indigenous peoples—but lower in others—
and to identify successful strategies for TB prevention accordingly.
Limitations
This systematic review was most limited by the dearth of published data. In some regions of 
the world, the most recent TB data were from more than 20 years ago, which hinders the 
ability to accurately assess the current burden of TB within those indigenous populations. As 
TB surveillance data for indigenous people are unavailable in many areas of the world, 
researchers calculated estimates of TB based on small studies that sometimes included fewer 
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than 1000 people. Although these estimates provide invaluable information, especially given 
the lack of information in general, the small sample sizes in many studies increase the 
uncertainty of disease estimates; the level of uncertainty around these measurements was 
unavailable in many cases. As such, differences observed between groups should be 
interpreted with caution. Moreover, non-standardized methodologies and wide variation in 
the scope of studies included in this review can limit comparability across studies. For 
example, comparing state or national data with data collected from smaller studies is 
especially challenging. Similarly, caution must be taken when comparing TB rates of 
indigenous groups from different years, even if they reside in the same country (e.g., 
Maharashtra and Madhya Tribes in India), as external factors, such as changes in TB 
programs, were not considered in this review. Furthermore, when comparison data were not 
available, published WHO TB prevalence and incidence rates were used; however, these data 
also have limitations for the purposes of comparison, as they are national estimates and may 
therefore not necessarily reflect the non-indigenous population living closest to the 
indigenous peoples studied. In addition, we recognize that each country with disaggregated 
data defines their indigenous groups differently, making direct comparisons difficult. As 
with any systematic review, publication bias was also a limitation.
CONCLUSIONS
This review highlights the disparate impact of TB on the world’s indigenous peoples. The 
results highlight a need to implement and improve TB surveillance in indigenous 
populations globally to ensure that the burden of TB in indigenous peoples is accurately 
reflected. The paucity of data that exist on the epidemiology of TB within indigenous 
peoples, particularly in low- and middle-income countries, demonstrates the need to invest 
more resources to assess the current TB burden and elucidate its underlying causes. 
Improved TB surveillance is needed to better measure, understand and address the 
underlying causes of disparities in TB between indigenous and non-indigenous peoples. 
Ultimately, this review reveals the need to prioritize indigenous populations worldwide in 
TB control.
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PRISMA diagram detailing paper selection process. PRISMA = Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses.
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The number of studies included in review by country. Countries with data include Canada (n 
= 17), India (n = 17), Brazil (n = 13), United States (n = 9), Australia (n = 6), Taiwan (n = 
5), Russia (n = 5), New Zealand (n = 4), China (n = 3), Greenland (n = 2), Thailand (n = 2), 
Venezuela (n = 2), Chad (n = 1), Ecuador (n = 1), Israel (n = 1), Mali (n = 1), Paraguay (n = 
1), Peru (n = 1) and Spain (n =1). Some studies in North America covered both Canada and 
the United States.
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Table 1
Search terminology utilized in the review process
Subject search: Tuberculosis/epidemiology, Tuberculosis/ethnology, with each continental ancestry group
Broad key word: ‘Tuberculosis’ with ‘indigenous people(s)’, ‘indigenous population(s)’, ‘tribe’ or ‘tribal’, ‘aboriginal’ or ‘aborigine’
Narrow key word: ‘Tuberculosis’ and any of the following: Maori, Inuit, American Indian, Native American, Alaska Natives, First Nations, 
Roma, Bushmen, Herdsmen, Hill People; Asia-specific: Adivasi, Lahu, Akha, Mon, Lua, Mbri, Karen, Hmong, Miao, Hui (Minority AND 
China); Africa-specific: Aka, Babenjelle, Babongo, Bacwa, Bagyeli, Baka, Bakola, Bakoya, Bambuti, Batwa, Pygmy, Aasax, Akie, Aweer, 
Barabaig, Dahalo, Datoga, Elmolo, Hadzabe, Hadza, Maasai, Ogiek, Sandawe, Sengwer, Waata, Yaaku, Amazigh, Imazighn, Berbers, Tuareg, 
Afar, Aka, Babendjelle, Boranna, Dinka, Fulani, Kanuri, Karamajong, Manjo, Nuer, Peul, Pygymy, Tuareg, Tubu, Wodaabe, Bassari, Bororo, 
Daza, Nemadi, Ogoni, Teda, Khoekhoe, Khoikhoi, Basarwa, Khwe, Nama, San (AND Africa), Tsumkwe; Far North-specific: Aleut, Alutor, 
Chelkancy, Chukchi, Chulymcy, Chuvancy, Dolgan, Ency, Evenk, Itelmen, Kamchadal, Kereki, Kety, Khanty, Koryak, Kumandincy, Mansi, 
Nanaicy, Negidalcy, Nenets, Nganasan, Nivkhy, Orochi, Oroki, Saami, Sami, Selkup, Shorcy, Soioty, Tazy, Telengity, Teleuty, Tofolar, Tubolar, 
Tuvin-Todjin, Udege, Ukagiry, Ulchi, Veps
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Table 2
Primary study methodology and scope of included studies
n (%) Study locations
Study design
 Cohort* 59 (65) North America (n = 21), Latin America (n = 11), Eastern Mediterranean (n = 1), Europe (n = 7), South-
East Asia (n = 2), Western Pacific (n = 17)
 Cross-sectional 29 (32) Africa (n = 2), North America (n = 1), Latin America (n = 7), South-East Asia (n = 19)
 Case control 3 (3) North America (n = 1), Europe (n = 1), Western Pacific (n = 1)
Scope
 National 29 (32) North America (n = 11), Latin America (n = 3), Europe (n = 2), South-East Asia (n = 2), Western Pacific 
(n = 11)
 Village/town/reserve 25 (27) Africa (n = 2), North America (n = 4), Latin America (n = 7), Europe (n = 2), South-East Asia (n = 10)
 Province/state/region 17 (19) North America (n = 6), Latin America (n = 2), Europe (n = 3), South-East Asia (n = 1), Western Pacific (n 
= 5)
 District 9 (10) Latin America (n = 1), Europe (n = 1), South-East Asia (n = 6), Western Pacific (n = 1)
 Facility 7 (8) North America (n = 1), Latin America (n = 3), Eastern Mediterranean (n = 1), South-East Asia (n = 2)
 City 4 (4) North America (n = 1), Latin America (n = 2), Western Pacific (n = 1)
*
Includes TB surveillance data. TB = tuberculosis.
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